Insider Transactions in Q2 2022 at United Therapeutics Corp (UTHR)
Insider Transaction List (Q2 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Apr 21
2022
|
Raymond Dwek |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$96,000
$48.11 P/Share
|
|
Apr 14
2022
|
Raymond Dwek |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,000
-100.0%
|
$382,000
$191.91 P/Share
|
|
Apr 14
2022
|
Raymond Dwek |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$96,000
$48.11 P/Share
|
|
Apr 07
2022
|
Raymond Dwek |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,000
-100.0%
|
$380,000
$190.11 P/Share
|
|
Apr 07
2022
|
Raymond Dwek |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+50.0%
|
$96,000
$48.11 P/Share
|
|
Apr 07
2022
|
Paul A Mahon EVP & GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct |
6,000
-4.94%
|
$1,110,000
$185.74 P/Share
|
|
Apr 07
2022
|
Paul A Mahon EVP & GENERAL COUNSEL |
BUY
Exercise of conversion of derivative security
|
Direct |
6,000
+12.37%
|
$666,000
$111.0 P/Share
|
|
Apr 07
2022
|
Christopher Patusky |
SELL
Sale (or disposition) back to the issuer
|
Direct |
2,000
-54.35%
|
$380,000
$190.11 P/Share
|
|
Apr 07
2022
|
Christopher Patusky |
BUY
Exercise of conversion of derivative security
|
Direct |
2,000
+35.21%
|
$126,000
$63.9 P/Share
|